Authors:
Greidinger, EL
Gaine, SP
Wise, RA
Boling, C
Housten-Harris, T
Wigley, FM
Citation: El. Greidinger et al., Primary pulmonary hypertension is not associated with scleroderma-like changes in nailfold capillaries, CHEST, 120(3), 2001, pp. 796-800
Authors:
Hull, KM
Griffith, L
Kuncl, RW
Wigley, FM
Citation: Km. Hull et al., A deceptive case of amyloid myopathy - Clinical and magnetic resonance imaging features, ARTH RHEUM, 44(8), 2001, pp. 1954-1958
Authors:
Stone, JH
Hoffman, GS
Merkel, PA
Min, YI
Uhlfelder, ML
Hellmann, DB
Specks, U
Allen, NB
Davis, JC
Spiera, RF
Calabrese, LH
Wigley, FM
Maiden, N
Valente, RM
Niles, JL
Fye, KH
McCune, JW
Clair, EWS
Luqmani, RA
Citation: Jh. Stone et al., A disease-specific activity index for Wegener's granulomatosis - Modification of the Birmingham Vasculitis Activity Score, ARTH RHEUM, 44(4), 2001, pp. 912-920
Citation: Ac. Gelber et al., Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: A series of 4 cases, J RHEUMATOL, 27(6), 2000, pp. 1542-1545
Authors:
Flavahan, NA
Flavahan, S
Liu, Q
Wu, S
Tidmore, W
Wiener, CM
Spence, RJ
Wigley, FM
Citation: Na. Flavahan et al., Increased alpha(2)-adrenergic constriction of isolated arterioles in diffuse scleroderma, ARTH RHEUM, 43(8), 2000, pp. 1886-1890
Authors:
Henry, PA
Atamas, SP
Yurovsky, VV
Luzina, I
Wigley, FM
White, B
Citation: Pa. Henry et al., Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in scleroderma, ARTH RHEUM, 43(12), 2000, pp. 2733-2742
Authors:
Wigley, FM
Wise, R
Haythornthwaite, J
Rand, C
Smith, EA
Maricq, HR
Middaugh, S
Silver, RM
Valter, I
Allenback, G
Arnold, J
Steedman, S
Risinger, A
King, A
Bielory, L
Attanasio, V
Tarantola, J
Centeno, L
Jacob, RG
Medsger, T
Jennings, R
Scheier, M
Vaughan, C
Wasko, MC
Steen, VD
Dunbar-Jacob, J
Tamres, L
Freedman, RR
Mayes, MD
Brejnak, C
Tindall, C
Bielory, L
Thompson, B
Frederick, M
Canner, M
Canner, J
Canner, P
Shaffer, TR
Hill, DR
Kaufmann, PG
Czajkowski, S
Geller, N
Hunsberger, S
Jennings, C
Stevens, WM
Hess, EV
Corson, JA
Jobe, JB
Smith, H
Tilley, B
Citation: Fm. Wigley et al., Comparison of sustained-release nifedipine and temperature biofeedback fortreatment of primary Raynaud phenomenon - Results from a randomized clinical trial with 1-year follow-up, ARCH IN MED, 160(8), 2000, pp. 1101-1108
Authors:
Badesch, DB
Tapson, VF
McGoon, MD
Brundage, BH
Rubin, LJ
Wigley, FM
Rich, S
Barst, RJ
Barrett, PS
Kral, KM
Jobsis, MM
Loyd, JE
Murali, S
Frost, A
Girgis, R
Bourge, RC
Ralph, DD
Elliott, CG
Hill, NS
Langleben, D
Schilz, RJ
McLaughlin, VV
Robbins, IM
Groves, BM
Shapiro, S
Medsger, TA
Gaine, SP
Horn, E
Decker, JC
Knobil, K
Citation: Db. Badesch et al., Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease - A randomized, controlled trial, ANN INT MED, 132(6), 2000, pp. 425
Authors:
White, B
Moore, WC
Wigley, FM
Xiao, HQ
Wise, RA
Citation: B. White et al., Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis, ANN INT MED, 132(12), 2000, pp. 947
Authors:
Seibold, JR
Korn, JH
Simms, R
Clements, PJ
Moreland, LW
Mayes, MD
Furst, DE
Rothfield, N
Steen, V
Weisman, M
Collier, D
Wigley, FM
Merkel, PA
Csuka, ME
Hsu, V
Rocco, S
Erikson, M
Hannigan, J
Harkonen, WS
Sanders, ME
Citation: Jr. Seibold et al., Recombinant human relaxin in the treatment of scleroderma - A randomized, double-blind, placebo-controlled trial, ANN INT MED, 132(11), 2000, pp. 871
Citation: Sm. Ling et Fm. Wigley, Raynaud's phenomenon in older adults - Diagnostic considerations and management, DRUG AGING, 15(3), 1999, pp. 183-195
Authors:
Gelber, AC
Wigley, FM
Stallings, RY
Bone, LR
Barker, AV
Baylor, I
Harris, CW
Hill, MN
Zeger, SL
Levine, DM
Citation: Ac. Gelber et al., Symptoms of Raynaud's phenomenon in an inner-city African-American community: Prevalence and self reported cardiovascular comorbidity, J CLIN EPID, 52(5), 1999, pp. 441-446
Authors:
Atamas, SP
Yurovsky, VV
Wise, R
Wigley, FM
Robinson, CJG
Henry, P
Alms, WJ
White, B
Citation: Sp. Atamas et al., Production of type 2 cytokines by CD8+lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis, ARTH RHEUM, 42(6), 1999, pp. 1168-1178